Project Grant R03AG088730
Award Date
9/17/24
Completion Date
8/31/26
Dollars Obligated
$318K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Boston, MA 02131, USA
Similar Awards
This federal Project Grant award of $676,912.00, funded by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to examine the impact of medications on functional recovery and successful transition back to home for older adults discharged to a skilled nursing facility (SNF) after a heart failure hospitalization. The central hypothesis is that certain commonly prescribed medications may impair rehabilitation participation, interfere with functional recovery, and decrease...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
This $302,960 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a study to detect heterogeneity in the treatment effects of intensive blood pressure control on cognitive outcomes and serious adverse events in older adults. The research team at the Harvard T.H. Chan School of Public Health will employ advanced statistical methods, including conventional subgroup analyses, risk score analyses, and effect score analyses, to analyze pooled...
This $679,475 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a national study examining antiepileptic medication use among patients with dementia residing in long-term care facilities. The study aims to: 1) characterize patient, provider, and facility factors associated with antiepileptic prescribing, 2) assess clinical outcomes of antiepileptic initiation compared to alternative medications, and 3) interview prescribers to understand...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a study to evaluate the impacts of the 340B Drug Pricing Program on Medicare Part D medication utilization, health outcomes, and disparities. The total award is $674,227, with a project period from November 2024 through October 2029. The study will use quasi-experimental methods to analyze Medicare Part D data and assess: 1) the effects of 340B program growth on Medicare Part D medication...
This Project Grant award, totaling $774,972, was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The project aims to quantify the effects of changes in the healthcare market, such as hospital mergers/acquisitions and openings/closures, on cardiovascular and cerebrovascular patient outcomes, understand the underlying mechanisms, and assess differential impacts on patient groups. The award supports a collaborative research effort...
This Project Grant award, provided by the National Institutes of Health's National Institute on Aging (CFDA 93.866 - Aging Research), supports a study on the impact of Medicare coverage choice on healthcare utilization and intergenerational transfers among Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The $1,846,173 award, spanning from August 2024 to April 2029, aims to investigate whether ADRD patients in Medicare Advantage (MA) plans experience more preventable...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Brown University will provide $2,238,104 from September 1, 2024 to August 31, 2027 to understand how prescribing cascades - where adverse events from one medication lead to the unnecessary prescription of another medication - arise and impact health outcomes among nursing home residents, especially those with Alzheimer's disease and related dementias. The research team will leverage nursing...
This federal Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $794,956 to the Hebrew Rehabilitation Center, doing business as Hebrew Senior Life, to evaluate the effectiveness of Transitional Care Management (TCM) and Chronic Care Management (CCM) services for Medicare beneficiaries, particularly those with frailty, dementia, and poor social determinants of health. The project aims to: 1) determine the impact of TCM and CCM on home time,...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Cedars-Sinai Medical Center is for $2,763,221 over approximately 5 years, with a start date of September 1, 2024. The project aims to examine the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on the number of days spent at home among persons living with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Specifically, the...